Oil soluble taggants

Information

  • Patent Grant
  • 11555790
  • Patent Number
    11,555,790
  • Date Filed
    Monday, August 24, 2020
    3 years ago
  • Date Issued
    Tuesday, January 17, 2023
    a year ago
Abstract
A process for detecting oil or lubricant contamination in the production of an article by adding a Stokes-shifting taggant to an oil or lubricant of a machine utilized to produce the article or a component thereof, irradiating the articles produced with a first wavelength of radiation, and monitoring the articles for emission of radiation at a second wavelength. The taggant can be in the form of a composition containing a Stokes-shifting taggant, which absorbs radiation at a first wavelength and emits radiation at a second wavelength, different from said first wavelength, dissolved or dispersed in an oil or lubricant.
Description
FIELD

Disclosed herein is a light wavelength converting material for taggant applications and quantitative diagnostics.


ENVIRONMENT

In the processing and packaging of various consumer products, oils, greases and lubricants may come into contact with the product.


Typically, lubricants can come into contact with consumer products due to leakage of lubricants through gaskets or seals, from sliding mechanisms, from drum systems, from gear boxes, from pumps, from sealed rolling bearing units, from chains and belts, and the like. For example, lubricants are used in a variety of machines commonly used in the preparation and packaging of produce for market.


Since lubricants of similar compositions are used throughout the various stages of produce treatment and packaging, it is often difficult for the manufacturer to locate the source of a particular lubricant. As such, the manufacturer is forced to conduct a time consuming search for the source of the lubricant which is lowering the quality of the manufactured products.


One possible way to detect the presence of undesired lubricants would be to add a taggant to the lubricant that could be readily detected on-line and at production speeds. However, suitable oil soluble taggants are not known to exist.


Therefore, it would be advantageous if an oil-soluble taggant could be developed that would enable inspection to be conducted on-line, in real time, during the production process.


SUMMARY

In one form, disclosed is a fluorescent taggant composition, comprising a Stokes-shifting taggant, which absorbs radiation at a first wavelength and emits radiation at a second wavelength, different from said first wavelength; and an oil or lubricant.


In another form, disclosed is a taggant composition, comprising an oil-soluble fluorescent taggant and an oil or lubricant.


In yet another form, disclosed is a compound comprising a tetrabutylammonium chloride complex of Indocyanine Green (ICG).





BRIEF DESCRIPTION OF THE DRAWINGS

The forms disclosed herein are illustrated by way of example, and not by way of limitation, in the figures of the accompanying drawings and in which like reference numerals refer to similar elements and in which:



FIG. 1 is a representation of the infrared absorption and emission peaks of the Indocyanine Green (ICG) complex taggant, illustrating the Stokes-shift;



FIG. 2 is a representation of the infrared absorption and emission peaks of a modified ICG-complex, illustrating a secondary emission peak;



FIG. 3 is a representation of the infrared absorption peak for the modified ICG-complex of Example 1;



FIG. 4 is a representation of the infrared excitation and emission peaks for the modified ICG-complex of Example 1; and



FIG. 5 is an H-nuclear magnetic resonance scan of the ICG-complex according to this invention.





DETAILED DESCRIPTION

Various aspects will now be described with reference to specific forms selected for purposes of illustration. It will be appreciated that the spirit and scope of the apparatus, system and methods disclosed herein are not limited to the selected forms. Moreover, it is to be noted that the figures provided herein are not drawn to any particular proportion or scale, and that many variations can be made to the illustrated forms. Reference is now made to FIGS. 1-5, wherein like numerals are used to designate like elements throughout.


Each of the following terms written in singular grammatical form: “a,” “an,” and “the,” as used herein, may also refer to, and encompass, a plurality of the stated entity or object, unless otherwise specifically defined or stated herein, or, unless the context clearly dictates otherwise. For example, the phrases “a device,” “an assembly,” “a mechanism,” “a component,” and “an element,” as used herein, may also refer to, and encompass, a plurality of devices, a plurality of assemblies, a plurality of mechanisms, a plurality of components, and a plurality of elements, respectively.


Each of the following terms: “includes,” “including,” “has,” “having,” “comprises,” and “comprising,” and, their linguistic or grammatical variants, derivatives, and/or conjugates, as used herein, means “including, but not limited to.”


Throughout the illustrative description, the examples, and the appended claims, a numerical value of a parameter, feature, object, or dimension, may be stated or described in terms of a numerical range format. It is to be fully understood that the stated numerical range format is provided for illustrating implementation of the forms disclosed herein, and is not to be understood or construed as inflexibly limiting the scope of the forms disclosed herein.


Moreover, for stating or describing a numerical range, the phrase “in a range of between about a first numerical value and about a second numerical value,” is considered equivalent to, and means the same as, the phrase “in a range of from about a first numerical value to about a second numerical value,” and, thus, the two equivalently meaning phrases may be used interchangeably.


It is to be understood that the various forms disclosed herein are not limited in their application to the details of the order or sequence, and number, of steps or procedures, and sub-steps or sub-procedures, of operation or implementation of forms of the method or to the details of type, composition, construction, arrangement, order and number of the system, system sub-units, devices, assemblies, sub-assemblies, mechanisms, structures, components, elements, and configurations, and, peripheral equipment, utilities, accessories, and materials of forms of the system, set forth in the following illustrative description, accompanying drawings, and examples, unless otherwise specifically stated herein. The apparatus, systems and methods disclosed herein can be practiced or implemented according to various other alternative forms and in various other alternative ways.


It is also to be understood that all technical and scientific words, terms, and/or phrases, used herein throughout the present disclosure have either the identical or similar meaning as commonly understood by one of ordinary skill in the art, unless otherwise specifically defined or stated herein. Phraseology, terminology, and, notation, employed herein throughout the present disclosure are for the purpose of description and should not be regarded as limiting.


Provided are new oil soluble, light wavelength-converting, preferably upconverting, compositions for taggant applications and quantitative diagnostics in connection with lubricants, such as by way of non-limiting example, the detection of errant lubricants on product that comes into contact with lubricated machinery. Other taggant applications are contemplated, including, but not limited to, anti-counterfeiting, brand protection, or verification that a machine contains a correct lubricant, and other possible applications. A detection system enables the development of near real time, low cost, compact, portable and highly sensitive detection, monitoring and diagnostics of modifications to manufacturing process systems in real world environments. It is the unique process (e.g. the conversion of visible light to infrared light, infrared to visible light and the upconversion of infrared to higher energy infrared) that enables high sensitivity detection against almost any sample or environmental background.


Using the system, theoretical particle detection (10−23 mol) of molecules added to analytic mixtures can be achieved through the use of on-line verification methods and even handheld detection applications. Detection sensitivity of 10−20 mol is possible in a variety of detection schemes, and even direct visual detection of 10−14 mol sensitivity has been demonstrated using a hand held 3.0 to 9.0 volt laser diode system against backgrounds of various colors and compositions. The narrow emission bandwidths and small particle size of these materials enable the simultaneous detection of multiple analytes (i.e. multiplexed assays).


According to the present invention, a detectable taggant compound is added to the various lubricants used in manufacturing and processing machinery, and advantageously taggant compounds having different characteristics are added into the lubricants at different processing locations, such that detection of one or more of these taggant compounds can enable rapid identification of the location of the source of lubricant contamination in the manufactured product.


Advantageously, the taggant compound is one which is detectable by fluorescence when it is exposed to particular wavelengths of light. In particular, a suitable taggant is one which absorbs energy at one wavelength and fluoresces/emits at a different wavelength. Such materials are well-known in the art as Stokes-shifting materials, and have recently found increasing use in inks for security marking of documents, such as banknotes and the like, to render such documents less susceptible to counterfeiting or copying.


However, most conventional Stokes-shifting and anti-Stokes shifting materials are composed of inorganic compounds, such as doped rare earth metal particles as described in U.S. Published Patent Application No. 2010/0219377, which are insoluble in lubricants. It would be advantageous if taggant compounds could be formulated to be soluble or dispersible in oils or lubricants.


According to the present invention, the taggant may be an organic compound comprised of purified crystals from naturally occurring chlorophyll. Suitable naturally-occurring chlorophyll crystals include Chlorophyll A (CAS number 1406-65-1) and Chlorophyll B (CAS number 519-62-0). These taggants are known as being down-converting or fluorescent, and are sensitive to excitation at a particular narrow bandwidth of IR light (680 nanometers). The taggant emits light at a different wavelength (715 nanometers). A similar compound may be a benze-indolium perchlorate or a benze-indolium tosolyate. Such materials absorb at around 670 nanometers and emit at a wavelength of about 713 nanometers. The chemical structure for Chlorophyll A is provided below.




embedded image



Since this compound is an organic chemical, it is readily dissolved in oils and lubricants.


In another form, an oil-soluble fluorescent material has been developed based on Indocyanine Green (ICG), the chemical structure of which is provided below.




embedded image


ICG is sodium 4-[2-[(1E,3E,5E,7Z)-7-[1,1-dimethyl-3-(4-sulfonatobutyl)-benzo[e]indol-2-ylidene]hepta-1,3,5-trienyl]-1,1-dimethyl-benzo[e]indol-3-ium-3-yl]butane-1-sulfonate, an infrared fluorescing compound currently used in the medical industry for imaging cells and blood flows in the human body, which in its conventional form is water-soluble.


The newly developed taggant is an ICG-complex available from Persis Science LLC, Andreas Pa. The chemical structure for a tetrabutylammonium chloride complexation of ICG is provided below and analytical structural information is provided in FIG. 5.




embedded image


The new ICG-complex is sensitive to a particular narrow absorption band of IR light between about 760 to about 810 nanometers (FIG. 3), and emits light at a different band between about 810 to about 840 nanometers (FIG. 4), with discrete absorbance peaks at about 785 nanometers (FIG. 4) and 805 nanometers (FIG. 1), and a discrete emission peak at about 840 nanometers (FIG. 1).


The ICG complex can be added to oils or lubricants in the amounts of approximately 1 ppb to 5%, preferably a range of 1 ppm to 2000 ppm, based on the weight of the lubricant.


Additionally, the nature of the ICG complexing agent can be modified to impart one or more secondary NIR reflectance wavelengths adjacent to the major emission peak at 840 nanometers. By utilizing such variations in the complexing agent, and adding differently complexed ICG compounds in lubricants at differing locations in the overall process, a single detector can be located at the end of the process, and when contamination is detected, the contaminated product can be removed from the process and further analyzed for said secondary NIR reflectance peaks, to determine the location of the source of contamination. FIG. 2 is an illustration of the absorption and emission peaks of a modified ICG-complex, showing a secondary emission peak of a longer wavelength on the shoulder of the primary emission peak.


The detection system of the present invention can be used in many processes and for consumer products which are susceptible to lubricant contamination during the manufacturing process, such as for example in the growing, collection, processing and/or packaging of packaged consumer goods, such as food products, beverages, tipped and non-tipped cigars, cigarillos, snus and other smokeless tobacco products, smoking articles, electronic cigarettes, distilled products, pharmaceuticals, frozen foods and other comestibles, and the like. Further applications could include clothing, furniture, finished wood or lumber or any other manufactured or packaged product wherein an absence of oil spotting is desired.


The taggant can be added to process machinery lubricants in minor amounts, so as to obtain ultimate concentrations in the oil/lubricant as low as between about 10 ppm and 100 ppm, typically at a concentration of about 50 ppm. At these taggant concentration levels the detection system can detect as little as 10 microliters of oil, or even as little as 1 microliter of tagged oil.


However, in order to provide for easier treatment of oils or lubricants already in place within various machines, it can be more convenient to formulate a master batch of the taggant in any particular oil, wherein the taggant is mixed at higher concentrations in the base oil/lubricant, such as from about 0.1 to about 5 wt % taggant, or even from about 0.2 to about 2 wt % taggant, in a balance of the base oil/lubricant. A portion of such tagged master batch is then easily transported and added to oils/lubricants which are already in place in the machines to be treated, for example by adding a small amount of the tagged master batch to the oil sump of the machine.


When the taggant is not an oil-soluble taggant, such as when it is an inorganic particle, an optional surfactant or dispersant additive can be added in an amount effective to facilitate dispersion of the taggant particles in the base oil. Such surfactants/dispersants are well-known in the art and their identities need not be repeated herein.


Specific forms will now be described further by way of example. While the following examples demonstrate certain forms of the subject matter disclosed herein, they are not to be interpreted as limiting the scope thereof, but rather as contributing to a complete description.


EXAMPLES
Example 1

500 mg of complexed ICG (Product No. OT-1013, available from Persis Science LLC of Andreas Pa.) is dispersed into 1.0 kg of Klüberoil 68 using a speedmixer. Klüberoil 68 is available from Klüber Lubrication North America L.P., Londonderry, N.H. The material is mixed for 10.0 minutes at a speed of 2100 RPM. The resulting master batch concentrate is slowly added to an additional 100.0 kg of Kluberoil 68 while stirring under high speed dispersion. A sample of the material is placed into a Shimadzu 5301 Fluorometer and the excitation and emission spectrographs are recorded. When excited at a wavelength of 785, a strong infrared emission is noted from 810 nanometers to 960 nanometers. See FIG. 3 for a representation of the infrared absorption peak for the ICG-complex of Example 1 and FIG. 4 for a representation of the infrared excitation and emission peaks for the ICG-complex of Example 1.


Example 2

The above example is modified slightly using a tetrabutylammonium bromide complexation of an Infrared dye IR830, available from Sigma-Aldrich of St. Louis, Mo. After mixing, it is noted that the material will produce fluorescence around 833 nanometers when excited with approximately 0.5 mW of 785 light.


Example 3

Upconverting nanoparticles, MED C-19 (Yb2O3:Er3+), were obtained from Persis Science, LLC in a slurry format in DMSO. The DMSO was dialyzed from the aqueous phase leaving the particles in aqueous phase. The particles were dried and dispersed into Kluberoil 68 using a Speedmixer. The dispersion was measured optically using a Spex Fluorolog-3. The oil suspension was excited at 970 nm and the detection occurred in the visible from 400 to 700 nm to determine the presence of the tagged oil.


Example 4

0.5 wt % of a europium chelate, available from Honeywell Corporation under the trade name of CD-335, was incorporated into 99.5 wt % of Lubriplate 220 oil using a horizontal media mill. Adequate detection was achieved using UV LED's at a wavelength of 363 nm and an APD detector with a 600 nm-700 nm notch filter.


Example 5

1.0 wt % of an infrared absorbing dithiolene dye commercially available from Epolin, Inc—358 Adams St. Newark N.J. 07105, was dissolved via mixing with 99 parts of Kluber Oil 220 under nitrogen with a stir bar for 5 hours. The resulting mixture was analyzed for infrared absorption. The absorption occurred from 800 nm to 1200 nm with a peak at around 1060 nm. The detection was achieved by contrast imaging with a Cognex In-Sight vision system and using a Monster LED light system with a wavelength of 850 nm. A Midwest optical filter 850 bandpass was used to isolate the absorption.


While the present invention has been described and illustrated by reference to particular forms, those of ordinary skill in the art will appreciate that the invention lends itself to variations not necessarily illustrated herein. For this reason, then, reference should be made solely to the appended claims for purposes of determining the true scope of the present invention.

Claims
  • 1. A compound comprising a tetrabutylammonium chloride complex of Indocyanine Green.
  • 2. The compound of claim 1, wherein the compound has the following chemical structure:
  • 3. The compound of claim 2, wherein the compound is configured to absorb radiation at a first wavelength and emit radiation at a second wavelength, different from the first wavelength.
  • 4. The compound of claim 3, wherein the first wavelength ranges from 760 nanometers to 810 nanometers and the second wavelength ranges from 810 nanometers to 960 nanometers.
RELATED APPLICATION

This application is a Divisional Application of U.S. application Ser. No. 14/795,674, filed Jul. 9, 2015, which is a continuation of U.S. application Ser. No. 13/338,971, filed Dec. 28, 2011, which claims benefit of U.S. Provisional Application No. 61/490,403, filed May 26, 2011, the entire contents of each of which are incorporated herein by reference.

US Referenced Citations (184)
Number Name Date Kind
3085581 Rosenberg et al. Apr 1963 A
3111950 Verbakel Nov 1963 A
3417241 Davis Dec 1968 A
3806727 Leonard et al. Apr 1974 A
3812349 Gugliotta et al. May 1974 A
3880289 Gray Apr 1975 A
3985581 Stachurski et al. Oct 1976 A
RE29298 Banks Jul 1977 E
4057721 deVial et al. Nov 1977 A
4175996 Battard et al. Nov 1979 A
4445520 Knight et al. May 1984 A
4480702 Kelly, Jr. Nov 1984 A
4657144 Martin et al. Apr 1987 A
4845374 White et al. Jul 1989 A
4858465 Molina Aug 1989 A
4971077 Dominguez et al. Nov 1990 A
5048543 Smith Sep 1991 A
5092349 Smith et al. Mar 1992 A
5134291 Ruhl, Jr. et al. Jul 1992 A
5265732 Long Nov 1993 A
5414270 Henderson et al. May 1995 A
5440919 Cooper Aug 1995 A
5462176 Hereford et al. Oct 1995 A
5471311 van den Bergh et al. Nov 1995 A
5476108 Dominguez et al. Dec 1995 A
5525516 Krutak et al. Jun 1996 A
5554408 Cain et al. Sep 1996 A
5554480 Patel et al. Sep 1996 A
5665538 Slater et al. Sep 1997 A
5669511 Satake et al. Sep 1997 A
5710046 Rutledge et al. Jan 1998 A
5715843 Hapke et al. Feb 1998 A
5764874 White Jun 1998 A
5804447 Albert et al. Sep 1998 A
5807605 Tingey et al. Sep 1998 A
5846830 Demello et al. Dec 1998 A
5887073 Fazzari et al. Mar 1999 A
5974860 Kuroda et al. Nov 1999 A
5990197 Escano et al. Nov 1999 A
5998211 Albert et al. Dec 1999 A
6025200 Kaish et al. Feb 2000 A
6058940 Lane May 2000 A
6060677 Ulrichsen et al. May 2000 A
6064032 Voss et al. May 2000 A
6123201 Atwell et al. Sep 2000 A
6135386 Garthaffner Oct 2000 A
6149719 Houle Nov 2000 A
6166366 Lewis et al. Dec 2000 A
6312958 Meyer et al. Nov 2001 B1
6380547 Gonzalez et al. Apr 2002 B1
6384359 Belcastro et al. May 2002 B1
6444143 Bawendi et al. Sep 2002 B2
6477227 Kaiser et al. Nov 2002 B1
6511756 Obuchi et al. Jan 2003 B1
6529273 Norris et al. Mar 2003 B1
6633043 Hegazi et al. Oct 2003 B2
6734383 Calcoen et al. May 2004 B1
6771365 Pirani et al. Aug 2004 B1
6795179 Kumar Sep 2004 B2
6809819 Vinjamoori et al. Oct 2004 B1
6830310 Iu et al. Dec 2004 B2
6905538 Auslander Jun 2005 B2
6914678 Ulrichsen et al. Jul 2005 B1
6926764 Bleikolm et al. Aug 2005 B2
7124944 Selinfreund et al. Oct 2006 B2
7142296 Cunningham et al. Nov 2006 B2
7153557 Rancien Dec 2006 B2
7157611 Banavali et al. Jan 2007 B2
7227148 Sato et al. Jun 2007 B2
7256398 Ross et al. Aug 2007 B2
7319039 Sullivan Jan 2008 B2
7378675 Ross et al. May 2008 B2
7391035 Kong et al. Jun 2008 B2
7441704 Ross Oct 2008 B2
7488945 Li et al. Feb 2009 B2
7538324 Deevi et al. May 2009 B2
7705144 Holmes Apr 2010 B2
7749438 Zeinali et al. Jul 2010 B2
7767457 Mun et al. Aug 2010 B2
7768643 Janssens et al. Aug 2010 B1
7787111 Kim et al. Aug 2010 B2
7800088 Ross et al. Sep 2010 B2
7812953 Tai et al. Oct 2010 B2
7816616 Kenny et al. Oct 2010 B2
7829162 Eskra et al. Nov 2010 B2
7842896 Calcoen et al. Nov 2010 B1
7919325 Eastwood et al. Apr 2011 B2
7938124 Izumiya et al. May 2011 B2
7985590 McNeil Jul 2011 B2
8415165 Liang et al. Apr 2013 B2
8641933 Purdy et al. Feb 2014 B2
8692148 Sommer, Jr. et al. Apr 2014 B1
9006599 Adams et al. Apr 2015 B2
9073091 Cadieux, Jr. Jul 2015 B2
9080987 Faenza Jul 2015 B2
9097668 Cadieux, Jr. Aug 2015 B2
9174245 Blanc et al. Nov 2015 B2
9244017 Cadieux, Jr. et al. Jan 2016 B2
9361561 Bown et al. Jun 2016 B2
9546966 Cadieux, Jr. et al. Jan 2017 B2
9733197 Cadieux, Jr. et al. Aug 2017 B2
9791407 Urey et al. Oct 2017 B2
10782279 Cadieux, Jr. et al. Sep 2020 B2
10866194 Faenza Dec 2020 B2
20010045378 Charles et al. Nov 2001 A1
20020074269 Hensley et al. Jun 2002 A1
20020094058 Kaiser et al. Jul 2002 A1
20020097833 Kaiser et al. Jul 2002 A1
20020122878 Kerns et al. Sep 2002 A1
20020158212 French et al. Oct 2002 A1
20030032039 Cunningham et al. Feb 2003 A1
20030034282 Safai Feb 2003 A1
20030036201 Nelson et al. Feb 2003 A1
20030058990 Kaiser et al. Mar 2003 A1
20030097833 Ingram et al. May 2003 A1
20030129283 Martinez Carballido Jul 2003 A1
20030141459 Hegazi et al. Jul 2003 A1
20030183326 O'Connor Oct 2003 A1
20030194052 Price et al. Oct 2003 A1
20040134504 Lane Jul 2004 A1
20050029469 Schroder et al. Feb 2005 A1
20050031838 Lagunowich et al. Feb 2005 A1
20050083720 Fukui et al. Apr 2005 A1
20050092336 Zielke et al. May 2005 A1
20050092408 Lauf et al. May 2005 A1
20050099475 Barreto May 2005 A1
20050236015 Goel et al. Oct 2005 A1
20050241989 Sant et al. Nov 2005 A1
20050276906 Metzger Dec 2005 A1
20060016735 Ito et al. Jan 2006 A1
20060081503 Wegner Apr 2006 A1
20060118741 Ross et al. Jun 2006 A1
20060131517 Ross et al. Jun 2006 A1
20060131518 Ross et al. Jun 2006 A1
20060186348 Nguyen et al. Aug 2006 A1
20060241499 Irion et al. Oct 2006 A1
20060246020 Cole et al. Nov 2006 A1
20060262318 Sullivan Nov 2006 A1
20060291872 Mei et al. Dec 2006 A1
20070023715 Ross et al. Feb 2007 A1
20070048761 Reep et al. Mar 2007 A1
20070084269 Quest et al. Apr 2007 A1
20070187617 Kong et al. Aug 2007 A1
20070239367 Odegard et al. Oct 2007 A1
20080030712 Tokhtuev et al. Feb 2008 A1
20080116272 Giering et al. May 2008 A1
20080121815 Agrawal et al. May 2008 A1
20090032733 Thabeth et al. Feb 2009 A1
20090047531 Bartley et al. Feb 2009 A1
20090097833 Imada Apr 2009 A1
20090104711 Sim Apr 2009 A1
20090185182 Kim et al. Jul 2009 A1
20090237645 Hamby et al. Sep 2009 A1
20090280341 Maruichi et al. Nov 2009 A1
20090321623 Ross et al. Dec 2009 A1
20100080456 Paul et al. Apr 2010 A1
20100163063 Fernando et al. Jul 2010 A1
20100219377 Ebert Sep 2010 A1
20100224795 Cole et al. Sep 2010 A1
20100226861 Cole et al. Sep 2010 A1
20100233447 Campbell Sep 2010 A1
20100290040 Berghmans Nov 2010 A1
20100320371 Agrawal et al. Dec 2010 A1
20110141272 Uto et al. Jun 2011 A1
20110151576 Perfect et al. Jun 2011 A1
20110168915 Yajima et al. Jul 2011 A1
20110216190 Shimazu et al. Sep 2011 A1
20120104278 Downing et al. May 2012 A1
20120267287 Bailey Oct 2012 A1
20120302474 Faenza Nov 2012 A1
20130082173 Cadieux, Jr. et al. Apr 2013 A1
20130179090 Conroy et al. Jul 2013 A1
20130188170 Wilkins Jul 2013 A1
20130320216 Aiko et al. Dec 2013 A1
20130320237 Cadieux et al. Dec 2013 A1
20140262966 Cadieux, Jr. Sep 2014 A1
20150008162 Cadieux, Jr. Jan 2015 A1
20150048250 Cadieux, Jr. et al. Feb 2015 A1
20150290684 Cadieux, Jr. Oct 2015 A1
20150315511 Faenza Nov 2015 A1
20150323459 Cadieux, Jr. Nov 2015 A1
20160108293 Cadieux, Jr. et al. Apr 2016 A1
20160131596 Cadieux, Jr. et al. May 2016 A1
20160131629 Cadieux, Jr. et al. May 2016 A1
Foreign Referenced Citations (46)
Number Date Country
2837315 Nov 2012 CA
20320957 Jul 2005 DE
10201107666 Oct 2012 DE
0146299 Jun 1985 EP
0223446 May 1987 EP
657028 Jul 1997 EP
0897762 Feb 1999 EP
2715320 Apr 2014 EP
2091416 Jul 1982 GB
S61290057 Dec 1986 JP
S64059095 Mar 1989 JP
H04-00473 Jan 1992 JP
H06066728 Mar 1994 JP
H09-309845 Dec 1997 JP
2000-273757 Oct 2000 JP
2002505426 Feb 2002 JP
2002513155 May 2002 JP
2004-524013 Aug 2004 JP
2005-037398 Feb 2005 JP
3907042 Jan 2007 JP
2009519459 May 2009 JP
2009-229466 Oct 2009 JP
2011-158425 Aug 2011 JP
2014512185 May 2014 JP
2014515487 Jun 2014 JP
WO-1991017265 Nov 1991 WO
WO-9207249 Apr 1992 WO
WO-9800243 Jan 1998 WO
WO-1999057417 Nov 1999 WO
WO-9957417 Nov 1999 WO
WO-2001025747 Apr 2001 WO
WO-2001025748 Apr 2001 WO
WO-2001025764 Apr 2001 WO
WO-2001025766 Apr 2001 WO
WO-2001025767 Apr 2001 WO
WO-2001025820 Apr 2001 WO
WO-2002068945 Sep 2002 WO
WO-2006058406 Jun 2006 WO
WO-2008049515 May 2008 WO
WO-2010007390 Jan 2010 WO
WO-2010018216 Feb 2010 WO
WO-2012030988 Mar 2012 WO
WO-2012050844 Apr 2012 WO
WO-2012162701 Nov 2012 WO
WO-2013181286 Dec 2013 WO
WO-2014168720 Oct 2014 WO
Non-Patent Literature Citations (63)
Entry
Notice of Allowance dated Oct. 7, 2020 in U.S. Appl. No. 13/904,968.
U.S. Office Action dated Feb. 23, 2021 for corresponding U.S. Appl. No. 14/883,200.
International Search Report of International Application No. PCT/US2014/026556 dated Aug. 5, 2014.
International Search Report of International Application No. PCT/US2012/039870 dated Jan. 14, 2013.
International Search Report of International Application No. PCT/US2013/043172 dated Aug. 6, 2013.
Victoria B. Rodriguez et al., “Encapsulation and stabilization of indocyanine green within poly (styrene-alt-maleic anhydride) block-poly (styrene) micelles for near-infrared imaging” Journal of Biomedical Options, SPIE—International Society for Optical Engineering, vol. 13 No. 1, Jan. 30, 2008, p. 14025-1-140025-10; XP002664215.
International Preliminary Report on Patentability of International Application No. PCT/US2014/026556 dated Sep. 15, 2015.
International Preliminary Report on Patentability of International Application No. PCT/US2013/043172 dated Dec. 2, 2014.
International Preliminary Report on Patentability of International Application No. PCT/US2012/039870 dated Nov. 26, 2013.
International Search Report and Written Opinion issued in International Patent Application No. PCT/US2015/060179, dated Feb. 8, 2016.
Office Action for corresponding Mexican Application No. MX/a/2013/013768 dated May 23, 2018 and English translation thereof.
Non-Final Office Action dated Nov. 7, 2017 in U.S. Appl. No. 15/653,377.
Notice of Allowance dated May 23, 2018 in U.S. Appl. No. 15/653,377.
Non-Final Office Action dated Oct. 19, 2016 in U.S. Appl. No. 14/994,972.
Notice of Allowance dated Apr. 5, 2017 in U.S. Appl. No. 14/994,972.
Non-Final Office Action dated Jan. 29, 2015 in U.S. Appl. No. 13/482,771.
Final Office Action dated Jun. 8, 2015 in U.S. Appl. No. 13/482,771.
Notice of Allowance dated Sep. 14, 2015 in U.S. Appl. No. 13/482,771.
Non-Final Office Action dated May 21, 2014 in U.S. Appl. No. 13/338,971.
Final Office Action dated Sep. 10, 2014 in U.S. Appl. No. 13/338,971.
Notice of Allowance dated Jan. 2, 2015 in U.S. Appl. No. 13/338,971.
Decision of Rejection for Japanese Application No. 2017-073848 dated Sep. 7, 2018.
Office Action dated Feb. 15, 2018 in Japanese Patent Application No. 2017-073848.
Office Action dated Mar. 29, 2016 in Japanese Patent Application No. 2014-512185.
Office Action dated Dec. 2, 2016 in Japanese Patent Application No. 2014-512185.
Notice of Allowance dated Aug. 29, 2018 in Japanese Patent Application No. 2014-512185.
Notice of Allowance dated May 16, 2018 in Canadian Patent Application No. 2,837,315.
Office Action for corresponding U.S. Appl. No. 14/883,200 dated Oct. 16, 2018.
Office Action for U.S. Appl. No. 14/883,200 dated Oct. 16, 2018.
Office Action for corresponding U.S. Appl. No. 14/938,561 dated Dec. 7, 2018.
Non-Final Office Action for corresponding U.S. Appl. No. 13/904,968 dated Feb. 1, 2019.
United States Office Action for corresponding U.S. Appl. No. 16/253,674 dated Mar. 15, 2019.
United States Office Action for corresponding U.S. Appl. No. 14/938,561 dated Mar. 20, 2019.
European Office Action for corresponding Application No. 12727705.1-1020 dated Mar. 7, 2019.
United States Office Action for U.S. Appl. No. 14/883,200, dated Apr. 29, 2019.
Notice Of Allowance for U.S. Appl. No. 14/795,674, dated May 15, 2019.
United States Notice Of Allowance for U.S. Appl. No. 14/938,561, dated Jul. 10, 2019.
United States Notice Of Allowance for corresponding U.S. Appl. No. 14/938,561 dated Jul. 10, 2019.
United States Office Action for corresponding U.S. Appl. No. 13/904,968, dated Aug. 8, 2019.
United States Office Action for U.S. Appl. No. 16/253,674, dated Sep. 3, 2019.
Japanese Office Action for corresponding Application No. 2017-525056, dated Aug. 27, 2019, English translation thereof.
European Office Action for corresponding Application No. 15813150-8-1230, dated Oct. 9, 2019.
United States Office Action for U.S. Appl. No. 16/127,711, dated Nov. 1, 2019.
Japanese Office Action for corresponding Application No. 2018-246546, dated Nov. 1, 2019, English translation thereof.
United States Notice of Allowance for U.S. Appl. No. 14/938,561, dated Dec. 9, 2019.
United States Office Action for U.S. Appl. No. 14/883,200, dated Dec. 26, 2019.
Canadian Office Action for corresponding Application No. 3,023,128, dated Dec. 16, 2019.
United States Office Action for U.S. Appl. No. 13/904,968, dated Feb. 4, 2020.
United States Notice of Allowance for U.S. Appl. No. 14/938,561, dated Feb. 11, 2020.
Japanese Office Action for corresponding Application No. 2017-525056, dated Mar. 3, 2020, English translation thereof.
United States Notice of Allowance for U.S. Appl. No. 16/127,711, dated Mar. 25, 2020.
United States Office Action for U.S. Appl. No. 14/883,200, dated May 8, 2020.
United States Notice of Allowance for U.S. Appl. No. 14/938,561, dated May 6, 2020.
United States Notice of Allowance for U.S. Appl. No. 14/795,674, dated Jun. 2, 2020.
United States Office Action for corresponding U.S. Appl. No. 13/904,968, dated Aug. 6, 2020.
Non-Final Office Action dated Apr. 13, 2021 in U.S. Appl. No. 16/909,186 (12 pages).
U.S. Final Office Action dated Jul. 30, 2021 in corresponding U.S. Appl. No. 14/883,200 (9 pages).
U.S. Office Action dated Aug. 23, 2021 for U.S. Appl. No. 16/909,186 (12 pages).
Notice of Allowance for U.S. Appl. No. 16/909,186 dated Dec. 21, 2021 (10 pages).
United States Non-Final Office Action for corresponding U.S. Appl. No. 17/000,766 dated Mar. 30, 2022 (28 pages).
European Office Action for corresponding EP Application No. 15813150.8 dated Mar. 16, 2022.
United States Final Office Action for U.S. Appl. No. 17/000,766 dated Jul. 6, 2022 (8 pages).
United States Notice of Allowance for U.S. Appl. No. 17/000,766, dated Sep. 21, 2022 (9 pages).
Related Publications (1)
Number Date Country
20200386691 A1 Dec 2020 US
Provisional Applications (1)
Number Date Country
61490403 May 2011 US
Divisions (1)
Number Date Country
Parent 14795674 Jul 2015 US
Child 17000531 US
Continuations (1)
Number Date Country
Parent 13338971 Dec 2011 US
Child 14795674 US